Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

How GSK Implemented Pivotal End-to-End Engagement Initiatives at Different Stage

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11154383
archived

Dr Marilyn Metcalf, Head of the Center of Innovation for GSK, at the 5th annual Patients as Partners 2018 program. Dr Metcalf shares how GSK implemented pivotal end-to-end engagement initiatives at different stages of development. Dr Metcalf walked the audience through some examples of the engagement initiatives supported by:

• Creation of a framework and toolkit that builds on existing infrastructure
• Networks of champions and project leads
• Project planning
• Emerging best practices being shared throughout the organization

Dr Metcalf will also be joining the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia where she leads a panel with patients and advocacy on Mapping Out the Patient Decision Making Journey. Patients as Partners US is the only conference that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. For more information visit www.theconferenceforum.org.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled